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Stroke Following Injection of a Melted Suppository
Saad Bitar, MD, and Camilo R. Gomez, MD Background and Purpose: Stroke following the intravenous injection of drugs may be secondary to the direct effect of the substance itself or from embolization by the inert vehicle used in the manufacturing process of the drug.
Case Description: We describe a 39-year-old man who developed a left homonymous hemianopia after intravenous injection of a melted suppository.
Conclusions: Paradoxical fat embolism should be added to the possible list of stroke mechanisms in intravenous drug abusers. (Stroke 1993; 24:741-743) KEY WORDS * embolism * substance abuse C ases of stroke secondary to the intravenous injection of various substances, particularly cocaine and other sympathomimetic drugs, continue to be reported in the literature.1-7 In general, these patients are believed to suffer the direct effects of the drug being injected. In a minority of instances, however, the inert vehicle used in the manufacture of medications may cause embolization and stroke.5, 6 We report a case of ischemic stroke following intravenous injection of a melted suppository by a young drug addict.
Case Report A 39-year-old man arrived at the ophthalmology clinic of Saint Louis University Medical Center exhibiting "vision changes" approximately 20 hours after injecting himself intravenously with two melted hydromorphone hydrochloride (Dilaudid; Knoll Pharmaceuticals, Whippany, N.J.) suppositories. Examination disclosed a left homonymous hemianopia, and he was transferred for neurological evaluation.
The patient, a registered nurse by profession, had been an intravenous opiate addict for many years and had recently been injecting himself intravenously with crushed hydromorphone tablets diluted in water. The day before admission, not having any more tablets, he melted two suppositories in hot water and injected them into his right antecubital vein. Retrospectively, he recalled observing a "layer of fat" floating in the syringe. Immediately after the injection, he noticed a burning sensation in his palms and soles, numbness around his lips, substernal chest pain, abdominal cramps, and "tunneling" of vision. These symptoms were followed by severe emesis that ceased when he went to sleep. The next morning, he remained nauseated and noted an inability to see to his left with either eye. The nausea improved over a few hours, but the persistence of his visual difficulty prompted him to seek medical attention. His past medical history was significant for WolffParkinson-White syndrome and hyperlipidemia type IV. There was no history of previous neurological disorders. His medications included digoxin, trazodone, and verapamil, and he was receiving methadone as part of a detoxification program.
When first seen, his blood pressure was 150/92 mm Hg in the supine position, and his pulse was 80 beats per minute and regular. His heart examination revealed a I/VI systolic murmur at the apex without radiation. The rest of his general examination was normal. Neurological examination revealed normal mental status. Cranial nerve examination was remarkable only for a congruous left homonymous hemianopia. Motor, sensory, and coordination examinations were intact. Muscle stretch reflexes were normally active, symmetrical, and accompanied by flexor plantar responses. The patient was able to walk on heels, toes, and tandem without difficulty.
A head computed tomographic scan without contrast ( Figure 1) refuse further evaluation and denied any additional symptoms. The homonymous hemianopia persisted.
Discussion
Stroke is a well-known complication of intravenous drug abuse,1-4 and several possible mechanisms may explain the clinical picture of our patient. First, the elevation of the erythrocyte sedimentation rate suggests the coexistence of an infectious, inflammatory, or autoimmune process. The lack of echocardiographic or microbiological evidence for bacterial endocarditis practically discards this as the possible source of embolism. Ideally, transesophageal echocardiography would have assisted in documenting the absence of vegetations and other potential sources of cardiogenic embolism. 8 Unfortunately, owing to the patient's refusal, this could not be done. Hypersensitivity vasculitis could also explain the elevated erythrocyte sedimentation rate, while being a potential cause of the stroke. Angiitis reported in the context of amphetamine abuse9 has been shown to affect the central nervous system but with an inherent predilection for involvement of arterioles, capillaries, and venules. However, patients affected by hypersensitivity vasculitis usually exhibit a protracted clinical course that includes many systemic and neurological symptoms.9 In our patient, the rapid occurrence of the stroke after the injection, the restricted involvement of a large cerebral artery, and the lack of recurrent or progressive symptomatology make vasculitis an unlikely cause of the stroke.
A second possibility is that during melting of the suppository, chemical changes of its components occurred, and the newly formed substances induced a systemic chemical reaction that affected the brain. Hydromorphone is a hydrogenated ketone of morphine, formulated in 3-mg rectal suppositories that include cocoa butter as the main inactive ingredient.'0 An extensive search of the literature failed to provide information about the effects of heating any of these substances. Finally, direct consultation with an expert in toxicology revealed that neither hydromorphone nor cocoa butter was likely to be changed into a different chemical compound by the temperature required for melting the suppository (A. Poklis, 
personal communication).
A third possible explanation for the mechanism of stroke is the induction of vasospasm by the substances being injected. pulmonary hypertension leading to the opening of functional arteriovenous shunts. 19 Although we have no direct evidence, it is possible that some of the systemic symptoms (e.g., chest pain and nausea) may have reflected acute pulmonary hypertension, thus permitting paradoxic embolization through an occult pulmonary arteriovenous shunt and occipital lobe infarction.
It is impossible to be sure which of these mechanisms was responsible for our patient's stroke because he was not fully evaluated. However, this case underscores the complexity of stroke occurring in the setting of intravenous drug abuse and the need for intensive diagnostic evaluation to clarify mechanisms.
